• LAST PRICE
    0.9450
  • TODAY'S CHANGE (%)
    Trending Down-0.0049 (-0.5158%)
  • Bid / Lots
    0.9200/ 4
  • Ask / Lots
    1.0000/ 2
  • Open / Previous Close
    0.9189 / 0.9499
  • Day Range
    Low 0.9110
    High 0.9600
  • 52 Week Range
    Low 0.8100
    High 7.7000
  • Volume
    59,466
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.9499
TimeVolumeTFFP
09:32 ET45010.9189
09:44 ET60000.911
09:53 ET6000.9299
09:55 ET37570.92
10:04 ET1050.9599
10:24 ET7400.92
10:26 ET1000.9596
10:33 ET1000.94
10:47 ET1000.95
10:51 ET8650.94
10:58 ET6000.95
11:05 ET5500.95
11:41 ET13000.94
11:43 ET10000.940101
11:48 ET10000.942451
11:50 ET45550.94
11:52 ET43620.9226
11:57 ET37030.92
12:08 ET19000.92
12:24 ET7800.96
12:26 ET30000.9475
12:32 ET20000.9354
12:35 ET17300.9477
12:46 ET29000.93
12:57 ET4040.9312
01:08 ET4000.9598
01:31 ET2000.9563
01:49 ET1000.956
01:51 ET1300.956
02:00 ET55800.93
02:02 ET2000.9573
02:14 ET5000.95
02:21 ET2000.93
02:23 ET1270.96
02:27 ET11000.93
03:15 ET11140.93
03:17 ET1000.935
03:19 ET1000.945
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTFFP
TFF Pharmaceuticals Inc
34.2M
-0.7x
---
United StatesTARA
Protara Therapeutics Inc
34.9M
-0.9x
---
United StatesIMMX
Immix Biopharma Inc
33.4M
-0.7x
---
United StatesSTSA
Satsuma Pharmaceuticals Inc
32.5M
-0.5x
---
United StatesBTTX
Better Therapeutics Inc
32.2M
-0.5x
---
United StatesABIO
ARCA Biopharma Inc
32.0M
-2.2x
---
As of 2023-01-28

Company Information

TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF), technology platform. TFF platform is designed to improve the solubility and absorption of poorly water-soluble drugs and is particularly suited to generate dry powder particles with properties targeted for inhalation delivery, especially to the deep lung, an area of extreme interest in respiratory medicine. TFF Pharmaceuticals has two lead drug candidates: Inhaled Voriconazole Powder (TFF Vori) and Inhaled Tacrolimus Powder (TFF Tac-Lac). The Company is engaged in the joint development of an inhaled SARS-CoV2 Monoclonal Antibody in collaboration with Augmenta BioWorks and a dry powder formulation of niclosamide in collaboration agreement. It is also actively engaged in the analysis and testing of dry powder formulations of several drugs and vaccines through topical, ocular and nasal applications.

Contact Information

Headquarters
2600 Via Fortuna Ste 360AUSTIN, TX, United States 78746-7983
Phone
---
Fax
302-655-5049

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$34.2M
Revenue (TTM)
$195.0K
Shares Outstanding
36.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.36
Book Value
$1.53
P/E Ratio
-0.7x
Price/Sales (TTM)
175.4
Price/Cash Flow (TTM)
---
Operating Margin
-17,735.84%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.